The effect of intravenous cadmium on exocrine and endocrine pancreatic functions in conscious dogs.
This study was conducted in conscious dogs to investigate the effect of cadmium on exocrine pancreatic secretion and plasma levels of pancreatic polypeptide (PP). Mongrel dogs weighing 20-25 kg were prepared with chronic gastric and pancreatic fistulas, and were acclimated for 3 wk prior to studies. The dogs were given iv infusion of saline, secretin at 25 U/kg/h, cadmium at 0.15 mg/kg/h, or various combinations of these compounds. During the infusion, pancreatic juice and blood samples were collected at regular intervals. Secretin infusion stimulated pancreatic secretions. Infusion of cadmium alone had no effect on pancreatic secretions and plasma levels of PP. When cadmium infusion was stopped with the background infusion of secretin, pancreatic secretions and plasma levels of PP were significantly increased. This latent effect of cadmium on pancreatic secretions and plasma levels of PP was abolished by an iv injection of 100 mg/kg atropine. These results indicate that cholinergic signaling may be involved in the effect of cadmium on pancreatic exocrine secretions and PP release. The current study suggests that cadmium may have diverse physiological functions in both exocrine and endocrine pancreatic cells.
Chowdhury
P
P
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock 72205.
Doi
R
R
Inoue
K
K
Rayford
P L
PL
D000818:Animals; D002104:Cadmium / Q000633:toxicity*; D004285:Dogs; D007262:Infusions, Intravenous; D007515:Islets of Langerhans / Q000187:drug effects* / Q000502:physiology; D010179:Pancreas / Q000187:drug effects* / Q000502:physiology; D010191:Pancreatic Polypeptide / Q000097:blood; D012633:Secretin / Q000494:pharmacology
D002104:Cadmium; D012633:Secretin; D010191:Pancreatic Polypeptide